Wavegate receives $26M for neuromodulation technology for chronic pain
Wavegate Corporation, a company that makes neuromodulation technology for chronic pain management, has secured $26 million in a Series A funding round led by UCEA Capital Partners Ltd. WHAT IT DOES
The Louisiana-based company offers its…